Quest Diagnostics Inc expected to post earnings of $2.86 a share - Earnings Preview

• Quest Diagnostics Inc DGX.N, is expected to show a rise in quarterly revenue when it reports results on October 22 for the period ending September 30 2026

• The Secaucus New Jersey-based company is expected to report a 8.2% increase in revenue to $3.046 billion from $2.82 billion a year ago, according to the mean estimate from 14 analysts, based on LSEG data.

• ​LSEG's mean analyst estimate for Quest Diagnostics Inc is for earnings of $2.86 per share.

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy," 9 "hold" and no "sell" or "strong sell."

• The mean earnings estimate of analysts was unchanged in the last three months. ​

• Wall Street's median 12-month price target for Quest Diagnostics Inc is $251.00, about 6.8% above its last closing price of $234.91

Previous quarterly performance (using preferred earnings measure in US dollars). ​

This summary was machine generated October 20 at 12:38 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)